Newsroom

Takeda Corporate Information

To learn about our parent company, Takeda Pharmaceutical Company Limited, please visit http://www.takeda.com/

Media Inquiries

For media inquiries or reporter requests for more information, contact our Corporate Communications via [email protected]. If you generally would like to contact us, please visit Contact Us.

Recent News Releases

August 1st, 202308/01/2023

National Urban League and Takeda Partner on a New Community-Based National Initiative to Advance Health Equity

June 20th, 202306/20/2023

Takeda Presents Full Data Set from Phase 3 ADVANCE-CIDP 1 Clinical Trial Investigating HYQVIA® as a Maintenance Therapy for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) at PNS Annual Meeting

April 11th, 202304/11/2023

Takeda Receives FDA Approval to Expand the Use of HYQVIA^® to Treat Primary Immunodeficiency in Children

April 3rd, 202304/03/2023

Takeda Announces New U.S. Corporate Social Responsibility (CSR) Program Partners

October 5th, 202210/05/2022

U.S. Food and Drug Administration Accepts Takeda’s Supplemental Biologics License Application for Use of TAKHZYRO^® (lanadelumab-flyo) to Prevent Hereditary Angioedema (HAE) Attacks in Children 2 Years of Age and Older

SEE ALL NEWS AND RELEASES >